Search

 
 
 
 
 
 
Ionis Touts Phase 3 Win, But Safety Worries Cloud Nerve Drug Study

IONIS TOUTS PHASE 3 WIN, BUT SAFETY WORRIES CLOUD NERVE DRUG STUDY

Two RNA-based drugs for the same disease, a rare, crippling nerve condition called familial amyloid polyneuropathy with no available...